Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LABCORP HOLDINGS INC. Director's Dealing 2019

Sep 25, 2019

30237_dirs_2019-09-25_6e7fbba8-b51b-43d6-ac13-fac6df7653d2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2019-09-23

Reporting Person: ANDERSON KERRII B (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-09-23 Common Stock M 2600 $98.49 Acquired 20533 Direct
2019-09-23 Common Stock S 2600 $171.85 Disposed 17933 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-09-23 Non-qualified Stock Options $98.49 M 2600 Disposed 2021-05-11 Common Stock (2600) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1200 Indirect

Footnotes

F1: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.

F2: On August 27, 2019, the reporting person contributed 1,200 shares of common stock to a grantor retained annuity trust for the benefit of certain of her family members and for which the reporting person is the annuitant. The
reporting person is the trustee of the trust.

F3: Director stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2008 Stock Incentive Plan.

F4: The options vested in three equal annual installments beginning on the date reflected in this column and are now fully exercisable.